JP2022518523A5 - - Google Patents
Info
- Publication number
- JP2022518523A5 JP2022518523A5 JP2021543122A JP2021543122A JP2022518523A5 JP 2022518523 A5 JP2022518523 A5 JP 2022518523A5 JP 2021543122 A JP2021543122 A JP 2021543122A JP 2021543122 A JP2021543122 A JP 2021543122A JP 2022518523 A5 JP2022518523 A5 JP 2022518523A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- pharmaceutically acceptable
- solvate
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962796459P | 2019-01-24 | 2019-01-24 | |
| US62/796,459 | 2019-01-24 | ||
| US201962873703P | 2019-07-12 | 2019-07-12 | |
| US62/873,703 | 2019-07-12 | ||
| US201962928223P | 2019-10-30 | 2019-10-30 | |
| US62/928,223 | 2019-10-30 | ||
| PCT/US2020/014777 WO2020154492A1 (en) | 2019-01-24 | 2020-01-23 | Gpr35 modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518523A JP2022518523A (ja) | 2022-03-15 |
| JP2022518523A5 true JP2022518523A5 (enExample) | 2023-02-07 |
| JP7588077B2 JP7588077B2 (ja) | 2024-11-21 |
Family
ID=71733100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543122A Active JP7588077B2 (ja) | 2019-01-24 | 2020-01-23 | Ｇｐｒ３５モジュレーター |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11053251B2 (enExample) |
| EP (1) | EP3914256B1 (enExample) |
| JP (1) | JP7588077B2 (enExample) |
| KR (1) | KR102863894B1 (enExample) |
| CN (1) | CN113631168B (enExample) |
| AU (1) | AU2020210930B2 (enExample) |
| BR (1) | BR112021014566A2 (enExample) |
| CA (1) | CA3127786A1 (enExample) |
| IL (1) | IL285074B2 (enExample) |
| MA (1) | MA54825A (enExample) |
| MX (1) | MX2021008941A (enExample) |
| TW (1) | TWI845600B (enExample) |
| WO (1) | WO2020154492A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI845600B (zh) | 2019-01-24 | 2024-06-21 | 美商普羅米修斯生物科學股份有限公司 | Gpr35調節劑 |
| CN114375339A (zh) | 2019-05-14 | 2022-04-19 | 普罗米修斯生物科学公司 | Tl1a患者选择方法、系统和装置 |
| WO2022020617A1 (en) * | 2020-07-23 | 2022-01-27 | Prometheus Biosciences, Inc. | Therapeutic agents targeting gpr35 |
| JP2025513455A (ja) | 2022-04-22 | 2025-04-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | 疼痛の治療のためのヘテロアリール化合物 |
| GB202303387D0 (en) * | 2023-03-08 | 2023-04-19 | Thirtyfivebio Ltd | Compounds |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005119252A2 (en) * | 2004-05-26 | 2005-12-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr35 for the treatment of metabolic-related disorders |
| GB1338235A (en) * | 1970-12-15 | 1973-11-21 | May & Baker Ltd | Azapurinones |
| GB1421970A (en) * | 1973-06-12 | 1976-01-21 | May & Baker Ltd | 8-azapurin-6-one derivatives |
| US4052390A (en) * | 1973-06-12 | 1977-10-04 | May & Baker Limited | Azapurinones |
| GB1561345A (en) | 1976-10-22 | 1980-02-20 | May & Baker Ltd | 8 - azapuring - 6 - ones |
| US4923874A (en) * | 1988-07-21 | 1990-05-08 | G. D. Searle & Co. | Use of 8-azapurin-6-one derivatives for control of hypertension |
| US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| FR2845993B1 (fr) | 2002-10-16 | 2005-02-11 | Univ Pasteur | Composes pharmaceutiques inhibiteurs specifiques de la pde5 du muscle lisse, compositions pharmaceutiques les contenant et utilisations therapeutiques |
| CA2558721A1 (en) * | 2004-02-27 | 2005-09-15 | Pfizer Inc. | Screening method for emulators of neural activity and digestive system using gpr35 |
| US20070287630A1 (en) | 2006-06-12 | 2007-12-13 | Driwater, Inc. | Moisturizing agent with nutrients |
| WO2012167053A1 (en) * | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| TWI707038B (zh) | 2013-08-05 | 2020-10-11 | 美商扭轉生物科技有限公司 | 重新合成之基因庫 |
| US20150273088A1 (en) | 2014-03-28 | 2015-10-01 | Washington University | Zaprinast analogues as glutaminase inhibitors and methods to predict response thereto |
| US10519373B2 (en) | 2014-06-29 | 2019-12-31 | Profile Products, L.L.C. | Bark and wood fiber growing medium |
| US10626180B2 (en) | 2017-04-20 | 2020-04-21 | Cedars-Sinai Medical Center | Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease |
| TW202014217A (zh) * | 2018-04-27 | 2020-04-16 | 美國錫安山醫學中心 | 標靶gpr35以治療發炎性腸病症的組合物及方法 |
| TWI845600B (zh) | 2019-01-24 | 2024-06-21 | 美商普羅米修斯生物科學股份有限公司 | Gpr35調節劑 |
| WO2020163713A1 (en) | 2019-02-08 | 2020-08-13 | Cedars-Sinai Medical Center | Methods, systems, and kits for treating inflammatory disease targeting skap2 |
| MA54903A (fr) | 2019-02-08 | 2021-12-15 | Cedars Sinai Medical Center | Méthodes, compositions et kits pour traiter une maladie inflammatoire ciblant il18r1 |
| CN114375339A (zh) | 2019-05-14 | 2022-04-19 | 普罗米修斯生物科学公司 | Tl1a患者选择方法、系统和装置 |
| WO2021108694A1 (en) | 2019-11-27 | 2021-06-03 | Cedars-Sinai Medical Center | Predicting extraintestinal manifestations of inflammatory bowel disease |
| WO2022020617A1 (en) | 2020-07-23 | 2022-01-27 | Prometheus Biosciences, Inc. | Therapeutic agents targeting gpr35 |
| JP2023551602A (ja) | 2020-11-13 | 2023-12-08 | プロメテウス バイオサイエンシーズ，インク． | Ｔｌ１ａを標的とする炎症性疾患の治療のための方法、システム、およびキット |
| WO2022140283A1 (en) | 2020-12-21 | 2022-06-30 | Cedars-Sinai Medical Center | Tl1a therapy compositions and methods of treatment therewith |
-
2020
- 2020-01-22 TW TW109102674A patent/TWI845600B/zh active
- 2020-01-23 MX MX2021008941A patent/MX2021008941A/es unknown
- 2020-01-23 CN CN202080024043.7A patent/CN113631168B/zh active Active
- 2020-01-23 MA MA054825A patent/MA54825A/fr unknown
- 2020-01-23 AU AU2020210930A patent/AU2020210930B2/en active Active
- 2020-01-23 BR BR112021014566A patent/BR112021014566A2/pt unknown
- 2020-01-23 IL IL285074A patent/IL285074B2/en unknown
- 2020-01-23 CA CA3127786A patent/CA3127786A1/en active Pending
- 2020-01-23 WO PCT/US2020/014777 patent/WO2020154492A1/en not_active Ceased
- 2020-01-23 KR KR1020217026911A patent/KR102863894B1/ko active Active
- 2020-01-23 EP EP20745502.3A patent/EP3914256B1/en active Active
- 2020-01-23 JP JP2021543122A patent/JP7588077B2/ja active Active
- 2020-01-23 US US16/751,092 patent/US11053251B2/en active Active
-
2021
- 2021-05-18 US US17/323,979 patent/US11773101B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512833A5 (enExample) | ||
| JP2024520481A5 (enExample) | ||
| JP2022553841A5 (enExample) | ||
| JP2021527638A5 (enExample) | ||
| JP2015500843A5 (enExample) | ||
| JP2022529311A5 (enExample) | ||
| JP2016506960A5 (enExample) | ||
| JP2012533630A5 (enExample) | ||
| JP2016505512A5 (enExample) | ||
| JP2015505296A5 (enExample) | ||
| JP2021522280A5 (enExample) | ||
| JP2020527588A5 (enExample) | ||
| JP2020521767A5 (enExample) | ||
| JP2012526728A5 (enExample) | ||
| RU2010143857A (ru) | Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибриторов parp и ингибиторов полимеризации тубулина | |
| JP2023553835A5 (enExample) | ||
| JP2021523200A5 (enExample) | ||
| JP2019532928A5 (enExample) | ||
| JP2016506962A5 (enExample) | ||
| JP2009534302A5 (enExample) | ||
| JP2020527175A5 (enExample) | ||
| JP2013510885A5 (enExample) | ||
| JP2018514544A5 (enExample) | ||
| JP2021526123A5 (enExample) | ||
| JP2011037841A5 (enExample) |